Latest Blogs

Dec 11, 2018
The National Breast Cancer Coalition (NBCC; @deadline2020) recently issued an important message about transforming Pink October Breast Cancer Month from awareness into action to have a better impact on prevention and treatment of breast cancer...
Dec 11, 2018
What do you do when a patient requests a different physician, and you suspect prejudice is the reason?
Dec 11, 2018
Mentors have the awesome responsibility, and privilege, of guiding the next generation of physicians, who in turn will come through medicine and make it better for both those who work in health care as well as the patients whose lives rely on it.
Dec 06, 2018
Dr. Colin D. Weekes and the Reverend Joel B. Guillemette had a thoughtful and personal conversation about how they approach deeply challenging questions of hope and mortality in their work following an ASCO town hall event.
Subscribe to this column

Matthew S. Katz, MD

Matthew S. Katz, MD, is the Medical Director of Radiation Oncology at Lowell General Hospital and a partner in Radiation Oncology Associates, PA. He is former Chair of the Communications Committee for the American Society for Radiation Oncology (ASTRO) and External Advisory Board member for Mayo Clinic Center for Social Media. He serves on ASCO's Social Media Working Group, ASTRO's Education Committee, and Massachusetts Medical Society's Communications Committee. His areas of prime interest are patient education and health empowerment. Follow Dr. Katz on Twitter @subatomicdoc.

Nov 15, 2018
During my career, pathologists have always been the “doctor’s doctor.” Why can't they be the "patient's doctor" as well?
Dec 06, 2017
Only 11% of randomized trials give enough detail to practically use in clinical practice. Here are five ways we can use internet-based communication to make it easier for academic innovators to get credit for their work, and  to implement new findings for our patients.
Jul 12, 2017
Here are 10 reasons why we should look at postoperative radiation for regional melanoma.
Jul 19, 2016
Drug companies play a key role in improving cancer care, but financial toxicity for patients continues to worsen. Eternal vigilance is the price of liberty from excessive drug costs, and we have an ethical obligation to hold pharmaceutical companies accountable.
Apr 08, 2016
We have discussed risk, biology, and the importance of complete reporting. So how do we decide to actually use RNI?
Apr 04, 2016
How we report clinical trials makes interpreting their results harder. Why shouldn’t we all have more information to make better decisions for our patients?

Pages